Workflow
购股权
icon
Search documents
敏实集团因购股权获行使合共发行65万股股份
Zhi Tong Cai Jing· 2025-12-16 11:31
敏实集团(00425)公布,于2025年12月16日因购股权获行使合共发行65万股股份,每股发行价23.85港 元。 ...
万成集团股份因购股权获行使而发行合共220万股
Zhi Tong Cai Jing· 2025-12-09 09:40
万成集团股份(01451)发布公告,于2025年12月9日,该公司因行使购股权(购股权乃根据于2018年5月15 日采纳的购股权计划而授出)而发行合共220万股。 ...
永利澳门授出485.6万份购股权
Zhi Tong Cai Jing· 2025-12-04 12:01
永利澳门(01128)发布公告,于2025年12月4日,本公司根据其于2023年5月25日采纳的购股权计划向五 名独立非执行董事(获授人)授出485.6万份购股权,以认购本公司股本中合共485.6万股每股面值0.001港 元的普通股,惟须待获授人接纳后,方可作实。 ...
天立国际控股授出合共1200万份购股权
Zhi Tong Cai Jing· 2025-12-02 14:42
天立国际控股(01773)发布公告,根据其于2018年6月24日采纳的购股权计划,公司于2025年12月2日向 合资格参与者合共授出1200万份购股权,以认购公司股本中每股面值0.1港元之普通股,须待承授人接 纳购股权后,方可作实。 ...
天立国际控股(01773)授出合共1200万份购股权
智通财经网· 2025-12-02 14:38
智通财经APP讯,天立国际控股(01773)发布公告,根据其于2018年6月24日采纳的购股权计划,公司于 2025年12月2日向合资格参与者合共授出1200万份购股权,以认购公司股本中每股面值0.1港元之普通 股,须待承授人接纳购股权后,方可作实。 ...
天立国际控股(01773.HK)授出1200万份购股权
Ge Long Hui· 2025-12-02 14:36
格隆汇12月2日丨天立国际控股(01773.HK)公告,公司于2025年12月2日向合资格参与者("承授人")合共 授出1200万份购股权,以认购公司股本中每股面值0.1港元普通股,须待承授人接纳购股权后,方可作 实。 ...
华领医药-B授出合共2000万份购股权
Zhi Tong Cai Jing· 2025-12-01 00:23
Core Points - The company announced the grant of stock options to three executive directors and 71 employees as part of its stock option plan approved in August 2018 [1] - The stock options allow the grantees the right to subscribe for a total of 20 million new shares at a par value of $0.001 each [1]
麦迪森控股:授出最多8592.23万份购股权
Zhi Tong Cai Jing· 2025-11-28 15:26
Core Viewpoint - Madison Holdings (08057) has entered into a third share option agreement with SRA, allowing SRA to acquire up to 85,922,330 shares at a price of HKD 1.03 per share, conditional upon the completion of a loan extension agreement [1] Group 1 - The company has agreed to grant share options to SRA at a nominal price of HKD 1.00 [1] - The share options can be exercised within the specified term of the agreement [1] - The completion of the share options is contingent upon the loan extension agreement becoming unconditional [1]
亚盛医药-B授出130.45万份受限制股份单位及73.66万份购股权
Zhi Tong Cai Jing· 2025-11-27 13:30
Core Viewpoint - As of the announcement date, the company has granted a total of 1,304,500 restricted stock units (RSUs) to 146 selected individuals under the 2022 Restricted Stock Unit Plan, which corresponds to 1,304,500 shares [1] Summary by Categories Restricted Stock Units - The company has awarded 1,304,500 RSUs to 146 selected individuals under the 2022 plan, with further grants expected in 2022 [1] Stock Options - The company has granted a total of 736,600 stock options to 34 recipients under the post-initial public offering stock option plan, which allows for the subscription of an equivalent number of ordinary shares, pending acceptance by the option recipients [1]
亚盛医药-B(06855)授出130.45万份受限制股份单位及73.66万份购股权
智通财经网· 2025-11-27 13:24
Core Viewpoint - As of the announcement date, the company has granted a total of 1,304,500 restricted stock units to 146 selected individuals under the 2022 Restricted Stock Unit Plan, which corresponds to 1,304,500 shares [1] Group 1 - The company has also granted a total of 736,600 stock options to 34 grantees under the post-IPO stock option plan, which can be exercised to subscribe for a total of 736,600 ordinary shares of the company, pending acceptance by the option grantees [1]